Back to top

AGREEMENT AND PLAN OF MERGER

Agreement and Plan of Merger

AGREEMENT AND PLAN OF MERGER | Document Parties: C Each Company | MDS (US) Inc | MDS Inc | Molecular Devices Corporation | Monument Acquisition Corp You are currently viewing:
This Agreement and Plan of Merger involves

C Each Company | MDS (US) Inc | MDS Inc | Molecular Devices Corporation | Monument Acquisition Corp

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: AGREEMENT AND PLAN OF MERGER
Governing Law: Delaware     Date: 1/29/2007
Industry: Scientific and Technical Instr.     Law Firm: Cooley Godward;Ropes Gray     Sector: Technology

AGREEMENT AND PLAN OF MERGER, Parties: c each company , mds (us) inc , mds inc , molecular devices corporation , monument acquisition corp
50 of the Top 250 law firms use our Products every day
 
Exhibit 2.1
 
AGREEMENT AND PLAN OF MERGER
by and among:
MDS Inc. ,
a company organized under the laws of Canada;
Monument Acquisition Corp. ,
a Delaware corporation; and
Molecular Devices Corporation,
a Delaware corporation
 
Dated as of January 28, 2007

 
 

 


 
Table Of Contents
         
    Page  
SECTION 1. THE OFFER
    1  
1.1 Tender Offer
    1  
1.2 Actions of Parent and Acquisition Sub
    3  
1.3 Actions of the Company
    4  
1.4 Board of Directors
    5  
1.5 Actions by Directors
    6  
1.6 Top-Up Option
    6  
SECTION 2. THE MERGER; EFFECTIVE TIME
    7  
2.1 Merger of Acquisition Sub into the Company
    7  
2.2 Effect of the Merger
    7  
2.3 Effective Time
    7  
2.4 Certificate of Incorporation and Bylaws; Directors
    7  
2.5 Conversion of Company Shares
    8  
2.6 Closing of the Company’s Transfer Books
    8  
2.7 Payment for Company Shares
    9  
2.8 Appraisal Rights
    10  
2.9 Further Action
    10  
SECTION 3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY
    10  
3.1 Due Organization and Good Standing; Subsidiaries
    11  
3.2 Certificate of Incorporation; Bylaws
    11  
3.3 Capitalization, Etc
    12  
3.4 SEC Filings; Financial Statements
    12  
3.5 Absence of Certain Changes
    13  
3.6 IP Rights
    13  
3.7 Title to Assets; Real Property
    16  
3.8 Contracts
    16  
3.9 Compliance with Legal Requirements
    17  
3.10 Legal Proceedings; Orders
    17  
3.11 Governmental Authorizations
    18  
3.12 Tax Matters
    18  

-i-


 
Table Of Contents
(CONTINUED)
         
    Page  
3.13 Employee Benefit Plans
    19  
3.14 Labor Matters
    20  
3.15 Environmental Matters
    21  
3.16 Insurance
    21  
3.17 Transactions with Affiliates
    21  
3.18 Authority; Binding Nature of Agreement
    21  
3.19 Vote Required
    22  
3.20 Non-Contravention; Consents
    22  
3.21 Board Approvals; Anti-Takeover; Company Rights Agreement
    22  
3.22 Opinion of Financial Advisor
    23  
3.23 Brokers
    23  
3.24 Schedule 14D-9
    23  
3.25 Customers; Distributors and Vendors
    23  
SECTION 4. REPRESENTATIONS AND WARRANTIES OF PARENT AND ACQUISITION SUB
    24  
4.1 Due Organization
    24  
4.2 Legal Proceedings
    24  
4.3 Authority; Binding Nature of Agreement
    24  
4.4 Non-Contravention; Consents
    25  
4.5 Not an Interested Stockholder
    25  
4.6 Financing
    25  
4.7 Ownership of Company Shares
    25  
4.8 Offer Documents
    25  
4.9 Information in Schedule 14D-9
    26  
SECTION 5. COVENANTS
    26  
5.1 Interim Operations of the Company
    26  
5.2 No Solicitation
    28  
5.3 Meeting of the Company’s Stockholders
    29  
5.4 Filings; Other Action
    30  
5.5 Access
    31  

-ii-


 
Table Of Contents
(CONTINUED)
         
    Page  
5.6 Interim Operations of Acquisition Sub
    31  
5.7 Publicity
    31  
5.8 Stock Options
    32  
5.9 Other Employee Benefits
    32  
5.10 Indemnification; Directors’ and Officers’ Insurance
    33  
SECTION 6. CONDITIONS TO EACH PARTY’S OBLIGATION TO EFFECT THE MERGER
    34  
6.1 Stockholder Approval
    34  
6.2 No Injunctions; Laws
    34  
6.3 Closing of Tender Offer
    35  
SECTION 7. TERMINATION
    35  
7.1 Termination
    35  
7.2 Effect of Termination
    37  
7.3 Termination Fee and Expense Reimbursement
    37  
SECTION 8. MISCELLANEOUS PROVISIONS
    38  
8.1 Amendment
    38  
8.2 Waiver
    38  
8.3 No Survival of Representations and Warranties
    39  
8.4 Entire Agreement; Counterparts
    39  
8.5 Applicable Law; Jurisdiction
    39  
8.6 Attorneys’ Fees
    39  
8.7 Payment of Expenses
    39  
8.8 Assignability
    40  
8.9 Notices
    40  
8.10 Severability
    41  
8.11 Obligation of Parent
    41  
8.12 Disclosure
    41  
8.13 Construction
    41  

-iii-


 
         
`
       
EXECUTION COPY
AGREEMENT AND PLAN OF MERGER
      This Agreement and Plan of Merger (“Agreement”) is made and entered into as of January 28, 2007, by and among: MDS Inc. , a company organized under the laws of Canada (“Parent”); Monument Acquisition Corp. , a Delaware corporation and an indirect wholly owned subsidiary of Parent and direct wholly owned subsidiary of MDS (US) Inc., a Delaware corporation (“Acquisition Sub”); and Molecular Devices Corporation , a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
Recitals
      A.  Parent, Acquisition Sub and the Company have determined that it is in the best interests of their respective stockholders for the Company to be acquired upon the terms and subject to the conditions set forth in this Agreement.
      B.  In furtherance of the contemplated acquisition of the Company, it is proposed that Acquisition Sub make a tender offer to acquire all of the issued and outstanding Company Shares upon the terms and subject to the conditions set forth in this Agreement. (Such tender offer, as it may be amended from time to time, is referred to in this Agreement as the “Offer.”)
      C.  Each Company Share accepted for payment pursuant to the Offer will be exchanged for $35.50 (the “Per Share Amount”), net to the seller in cash.
      D.  It is further proposed that, after acquiring Company Shares pursuant to the Offer, Acquisition Sub merge with and into the Company upon the terms and subject to the conditions set forth in this Agreement (the merger of Acquisition Sub into the Company being referred to in this Agreement as the “Merger”), which will result in the Company becoming a wholly owned subsidiary of MDS (US) Inc.
Agreement
     The parties to this Agreement, intending to be legally bound, agree as follows:
SECTION 1 . THE OFFER
      1.1 Tender Offer .
           (a) Unless this Agreement shall have previously been validly terminated in accordance with Section 7, as promptly as practicable, but in any event within fifteen business days, after the date of this Agreement, Acquisition Sub shall commence (within the meaning of Rule 14d-2 under the Exchange Act) the Offer for all of the outstanding Company Shares (including any Company Shares subject to repurchase rights in favor of the Company) at a price per Company Share equal to the Per Share Amount. (The date on which Acquisition Sub

 


 
commences the Offer, within the meaning of Rule 14d-2 under the Exchange Act, is referred to in this Agreement as the “Offer Commencement Date.”)
           (b) Unless the Offer is extended in accordance with Section 1.1(d), within one business day after the later of: (i) the earliest date as of which Acquisition Sub is permitted under applicable law to accept for payment Company Shares tendered pursuant to the Offer; and (ii) the earliest date as of which each of the conditions set forth in Annex I (the “Offer Conditions”) shall have been satisfied or waived, Acquisition Sub shall (and Parent shall cause Acquisition Sub to) accept for payment all Company Shares validly tendered pursuant to the Offer (and not validly withdrawn). The obligation of Acquisition Sub to accept for payment Company Shares validly tendered pursuant to the Offer shall be subject only to the satisfaction or waiver of each of the Offer Conditions (and shall not be subject to any other conditions). As promptly as possible after the acceptance for payment of any Company Shares tendered pursuant to the Offer, Acquisition Sub shall pay for such Company Shares. Acquisition Sub shall be entitled to deduct and withhold from the consideration otherwise payable to any holder of Company Shares tendering Company Shares to Acquisition Sub pursuant to the Offer such amounts as Acquisition Sub is required to deduct and withhold with respect to the making of such payment under the Code or any provision of state, local or foreign tax law. To the extent amounts are so withheld and paid over to the appropriate taxing authority by Acquisition Sub, such withheld amounts shall be treated for all purposes as having been paid to the holder of Company Shares in respect of which such deduction and withholding was made by Acquisition Sub.
           (c) Acquisition Sub expressly reserves the right to waive any of the Offer Conditions without the prior written consent of the Company. Notwithstanding anything to the contrary contained in this Agreement, neither Parent nor Acquisition Sub shall (without the prior written consent of the Company):
                (i) change or waive the Minimum Condition (as defined in Annex I);
                (ii) decrease the number of Company Shares sought to be purchased by Acquisition Sub in the Offer;
                (iii) reduce the price per share to be paid pursuant to the Offer;
                (iv) extend or otherwise change the expiration date of the Offer (except to the extent required or permitted pursuant to Section 1.1(d));
                (v) change the form of consideration payable in the Offer;
                (vi) amend or modify any of the Offer Conditions in any manner adversely affecting, or that could reasonably be expected to have an adverse effect on, any of the holders of Company Shares or impose any condition to the Offer in addition to the Offer Conditions; or
                (vii) amend, modify or supplement any of the terms of the Offer in any manner adversely affecting, or that could reasonably be expected to have an adverse effect on, any of the holders of Company Shares.

2


 
           (d) Unless extended as provided in this Agreement, the Offer shall expire on the date (the “Initial Expiration Date”) that is 20 business days (calculated as set forth in Rule 14d-1(g)(3) and Rule 14e-1(a) under the Exchange Act) after the Offer Commencement Date. Notwithstanding the foregoing, if, on the Initial Expiration Date or any subsequent date as of which the Offer is scheduled to expire, any Offer Condition is not satisfied and has not been waived, then: (i) Acquisition Sub may extend (and re-extend) the Offer and its expiration date beyond the Initial Expiration Date or such other date for one or more periods ending no later than June 30, 2007, to permit such Offer Condition to be satisfied; and (ii) to the extent requested by the Company from time to time, Acquisition Sub shall extend (and re-extend) the Offer and its expiration date beyond the Initial Expiration Date or such other date for one or more periods ending no later than June 30, 2007, to permit such Offer Condition to be satisfied. The Offer may not be terminated prior to its expiration date (as such expiration date may be extended and re-extended in accordance with this Agreement), unless this Agreement is validly terminated in accordance with Section 7.
           (e) Acquisition Sub may, in its discretion, elect to provide for a subsequent offering period (and one or more extensions thereof) in accordance with Rule 14d-11 under the Exchange Act following the Acceptance Time (as defined in Section 1.4(a)).
      1.2 Actions of Parent and Acquisition Sub .
           (a) On the Offer Commencement Date, Parent and Acquisition Sub shall: (i) cause to be filed with the SEC a Tender Offer Statement on Schedule TO with respect to the Offer, which will contain or incorporate by reference Acquisition Sub’s offer to purchase and related letter of transmittal (the form of such letter of transmittal shall be subject to the approval of the Company, which approval shall not be unreasonably withheld or delayed) and the related form of summary advertisement (such Tender Offer Statement on Schedule TO and all exhibits, amendments and supplements thereto being referred to collectively in this Agreement as the “Offer Documents”); and (ii) cause the Offer Documents to be disseminated to holders of Company Shares to the extent required by applicable Legal Requirements. The Company shall promptly furnish to Parent all information concerning the Company that may be reasonably requested by Parent in connection with any action contemplated by this Section 1.2(a). Parent and Acquisition Sub shall cause the Offer Documents to comply in all material respects with the applicable requirements of the Exchange Act and the rules and regulations thereunder. The Company and its counsel shall be given reasonable opportunity to review and comment on the Offer Documents (including any amendment or supplement thereto) prior to the filing thereof with the SEC or the dissemination thereof to the Company’s stockholders, and Parent and Acquisition Sub will give reasonable good faith consideration to any such comments. Parent and Acquisition Sub shall promptly provide the Company and its counsel with a copy or a description of any comments received by Parent or Acquisition Sub (or by counsel to Parent or Acquisition Sub) from the SEC or its staff with respect to the Offer Documents. Each of Parent and Acquisition Sub shall respond promptly to any comments of the SEC or its staff with respect to the Offer Documents or the Offer.
           (b) To the extent required by the applicable requirements of the Exchange Act and the rules and regulations thereunder: (i) each of Parent, Acquisition Sub and the Company shall correct promptly any information provided by it for use in the Offer Documents if such

3


 
information shall have become false or misleading in any material respect; and (ii) each of Parent and Acquisition Sub shall take all steps necessary to promptly cause the Offer Documents, as supplemented or amended to correct such information, to be filed with the SEC and to be disseminated to holders of Company Shares. The Company shall promptly furnish to Parent all information concerning the Company that may be reasonably requested by Parent in connection with any action contemplated by this Section 1.2(b).
           (c) Without limiting the generality of Section 8.11, Parent shall cause to be provided to Acquisition Sub all of the funds necessary to purchase any Company Shares that Acquisition Sub becomes obligated to purchase pursuant to the Offer, and shall cause Acquisition Sub to perform, on a timely basis, all of Acquisition Sub’s obligations under this Agreement.
      1.3 Actions of the Company .
           (a) On or as promptly as practicable after the Offer Commencement Date, the Company shall file with the SEC and (following or contemporaneously with the initial dissemination of the Offer Documents to holders of Company Shares) disseminate to holders of Company Shares a Solicitation/Recommendation Statement on Schedule 14D-9 (together with any amendments or supplements thereto, the “Schedule 14D-9”) that, subject to Section 1.3(b), shall contain the recommendation of the Company’s Board of Directors that stockholders of the Company accept the Offer and tender their Company Shares pursuant to the Offer and adopt this Agreement (the “Company Board Recommendation”). The Company shall cause the Schedule 14D-9 to comply in all material respects with the applicable requirements of the Exchange Act and the rules and regulations thereunder. Parent and its counsel shall be given reasonable opportunity to review and comment on the Schedule 14D-9 (including any amendment or supplement thereto) prior to the filing thereof with the SEC or dissemination thereof to the Company’s stockholders, and the Company will give reasonable good faith consideration to any such comments. The Company shall promptly provide Parent and its counsel with a copy or a description of any comments received by the Company (or its counsel) from the SEC or its staff with respect to the Schedule 14D-9, and the Company shall respond promptly to any such comments. To the extent required by the applicable requirements of the Exchange Act and the rules and regulations thereunder: (i) each of Parent, Acquisition Sub and the Company shall promptly correct any information provided by it for use in the Schedule 14D-9 if that such information shall have become false or misleading in any material respect; and (ii) the Company shall take all steps necessary to cause the Schedule 14D-9, as supplemented or amended to correct such information, to be filed with the SEC. Parent and Acquisition Sub shall promptly furnish to the Company all information concerning Parent or Acquisition Sub that may be reasonably requested in connection with any action contemplated by this Section 1.3(a). To the extent reasonably practicable, the Company, Parent and Acquisition Sub shall cause the Schedule 14D-9 to be mailed or otherwise disseminated to the Company’s stockholders together with the Offer Documents disseminated to the Company’s stockholders.
           (b) Notwithstanding anything to the contrary contained in this Agreement, the Company’s Board of Directors may withdraw, modify, amend or qualify the Company Board Recommendation if it determines in good faith (after consultation with counsel) that failure to do

4


 
so would create a material risk of a breach by the Company’s Board of Directors of its fiduciary duties to the Company’s stockholders.
           (c) In connection with the Offer, the Company shall instruct its transfer agent to furnish to Acquisition Sub a list, as of a recent date, of the record holders of Company Shares and their addresses, as well as mailing labels containing such names and addresses. The Company will furnish Acquisition Sub with such additional information (including any security position listings in the Company’s possession) and assistance as Acquisition Sub may reasonably request for purposes of communicating the Offer to the holders of Company Shares. All information furnished in accordance with this Section 1.3(c) shall be held in confidence by Parent and Acquisition Sub in accordance with the requirements of the letter agreement, dated November 22, 2006, between Parent and the Company (the “Confidentiality Agreement”), and shall be used by Parent and Acquisition Sub only in connection with the communication of the Offer and the dissemination of any proxy or information statement relating to the Merger to the holders of Company Shares.
      1.4 Board of Directors .
           (a) If requested by Parent, following the first time at which Acquisition Sub accepts for payment any Company Shares tendered pursuant to the Offer (the “Acceptance Time”), the Company will, subject to compliance with applicable Legal Requirements, use reasonable efforts to take all actions necessary to cause persons designated by Parent to become directors of the Company so that the total number of such persons equals that number of directors, rounded up to the next whole number, determined by multiplying: (i) the total number of directors on the Company’s Board of Directors; by (ii) the percentage that the number of Company Shares purchased by Acquisition Sub pursuant to the Offer bears to the total number of Company Shares outstanding at the Acceptance Time; provided, however , that in no event shall Parent be entitled to designate any directors to serve on the Company’s Board of Directors unless it is the beneficial owner of Company Shares entitling it to exercise at least a majority of the voting power of the outstanding Company Shares. The Company will use its reasonable efforts to secure the resignation of directors or to increase the size of the Company’s Board of Directors (or both) to the extent necessary to permit Parent’s designees to be elected to the Company’s Board of Directors in accordance with this Section 1.4(a); provided, however , that prior to the Effective Time, the Company’s Board of Directors shall always have at least two Continuing Directors.
           (b) The Company’s obligation to cause Parent’s designees to be elected or appointed to the Company’s Board of Directors shall be subject to Section 14(f) of the Exchange Act and Rule 14f-1 thereunder. The Company shall promptly take all actions, and shall include in the Schedule 14D-9 such information with respect to the Company and its officers and directors, as Section 14(f) of the Exchange Act and Rule 14f-1 thereunder require in order to fulfill its obligations under this Section 1.4, so long as Parent shall have provided to the Company all information with respect to Parent and its designees, officers, directors and Affiliates required by Section 14(f) of the Exchange Act and Rule 14f-1 thereunder. Parent shall promptly supply to the Company in writing, and shall be solely responsible for, all such information.

5


 
      1.5 Actions by Directors . Following the election or appointment of Parent’s designees to the Company’s Board of Directors pursuant to Section 1.4(a), and until the Effective Time, the approval of the Company’s Board of Directors, including the approval of a majority of the Continuing Directors, shall be required to authorize: (i) any amendment to or termination of this Agreement by the Company; (ii) any amendment to the Company’s certificate of incorporation or bylaws; (iii) any extension of time for the performance of any of the obligations or other acts of Parent or Acquisition Sub; (iv) any waiver of compliance with any covenant of Parent or Acquisition Sub or any condition to any obligation of the Company or any waiver of any right of the Company under this Agreement; (v) any withdrawal, modification, amendment or qualification by the Company’s Board of Directors of the Company Board Recommendation; and (vi) any other consent or action by the Company’s Board of Directors with respect to this Agreement, other than with respect to Section 1.6, or the Merger that adversely affects or could reasonably be expected to adversely affect any of the holders of Company Shares.
      1.6 Top-Up Option .
           (a) The Company hereby irrevocably grants to Acquisition Sub an option (the “Top-Up Option”), exercisable subject to and upon the terms and conditions set forth in this Section 1.6, to purchase that number of Company Shares (the “Top-Up Option Company Shares”) equal to the lesser of: (i) the number of Company Shares that, when added to the number of Company Shares directly or indirectly owned by Parent or Acquisition Sub at the time of such exercise, shall constitute one share more than 90% of the Company Shares taking into account the issuance of the Top-Up Option Company Shares) and (ii) the number of Company Shares that is one (1) share less than 20% of the Company Shares issued and outstanding as of the date of this Agreement, at a price per share equal to the Per Share Amount; provided that in no event shall the Top-Up Option be exercisable for a number of Company Shares in excess of the Company’s then authorized and unissued Company Shares (giving effect to Company Shares reserved for issuance under the Company Option Plans as if such shares were outstanding).
           (b) Provided that no Legal Requirement shall prohibit the exercise of the Top-Up Option or the delivery of the Top-Up Option Company Shares in respect thereof, Acquisition Sub may exercise the Top-Up Option, in whole but not in part, at any one time after the Acceptance Time and prior to the earlier to occur of (i) the Effective Time and (ii) the termination of this Agreement pursuant to Section 7.
           (c) In the event that Acquisition Sub wishes to exercise the Top-Up Option, Parent shall send to the Company a written notice (a “Top-Up Exercise Notice,” the date of which notice is referred to herein as the “Top-Up Notice Date”) specifying the number of Top-Up Option Company Shares, the aggregate purchase price therefore and the place, time and date for the closing of the purchase and sale pursuant to the Top-Up Option (the “Top-Up Closing”). At the Top-Up Closing, Acquisition Sub shall, and Parent shall cause Acquisition Sub to, pay the Company the aggregate purchase price required to be paid for the Top-Up Option Company Shares either in cash or with a promissory note having a principal amount equal to such purchase price or any combination thereof.
           (d) Parent and Acquisition Sub acknowledge that the Company Shares that Acquisition Sub may acquire upon exercise of the Top-Up Option will not be registered under

6


 
the 1933 Act and will be issued in reliance upon an exemption thereunder for transactions not involving a public offering. Each of Parent and Acquisition Sub hereby represents and warrants to the Company that Acquisition Sub is, and will be, upon the purchase of the Top-Up Option Company Shares, an “accredited investor”, as defined in Rule 501 of Regulation D under the 1933 Act. Acquisition Sub agrees that the Top-Up Option and the Top-Up Option Company Shares to be acquired upon exercise of the Top-Up Option are being and will be acquired by Acquisition Sub for the purpose of investment and not with a view to, or for resale in connection with, any distribution thereof (within the meaning of the 1933 Act).
SECTION 2 . THE MERGER; EFFECTIVE TIME
      2.1 Merger of Acquisition Sub into the Company. Upon the terms and subject to the conditions set forth in this Agreement and in accordance with the Delaware General Corporation Law (the “DGCL”), at the Effective Time (as defined in Section 2.3), Acquisition Sub shall be merged with and into the Company, and the separate existence of Acquisition Sub shall cease. The Company will continue as the surviving corporation in the Merger (the “Surviving Corporation”).
      2.2 Effect of the Merger. The Merger shall have the effects set forth in this Agreement and in the applicable provisions of the DGCL.
      2.3 Effective Time. As soon as practicable after the satisfaction or waiver of the conditions set forth in Section 6, the parties hereto shall cause a properly executed certificate of merger conforming to the requirements of the DGCL (the “Certificate of Merger”) to be filed with the Secretary of State of the State of Delaware. The Merger shall become effective at the time the Certificate of Merger is filed with the Secretary of State of the State of Delaware, or at such later time as is agreed to by the parties hereto and specified in the Certificate of Merger (the time at which the Merger becomes effective being referred to in this Agreement as the “Effective Time”). At 10:00 a.m. (Pacific time) on the date on which the Certificate of Merger is to be so filed, a closing shall be held at the offices of Cooley Godward Kronish llp , 3175 Hanover Street, Palo Alto, California (or such other place or time as Parent and the Company may jointly designate) for the purpose of confirming the satisfaction or waiver of each of the conditions set forth in Section 6.
      2.4 Certificate of Incorporation and Bylaws; Directors . Unless otherwise jointly determined by Parent and the Company prior to the Effective Time:
      (a) the Certificate of Incorporation of the Surviving Corporation shall be amended and restated as of the Effective Time to conform to Exhibit B;
      (b) subject to Section 5.10(a), the Bylaws of the Surviving Corporation shall be amended and restated as of the Effective Time to conform to the Bylaws of Acquisition Sub as in effect immediately prior to the Effective Time; and
      (c) the directors of the Surviving Corporation immediately after the Effective Time shall be the respective individuals who are directors of Acquisition Sub immediately prior to the Effective Time.

7


 
      2.5 Conversion of Company Shares. Subject to Section 2.8, at the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Acquisition Sub, the Company or any stockholder of the Company:
      (a) any Company Shares then held by the Company (or held in the Company’s treasury) shall cease to exist, and no consideration shall be paid in exchange therefor;
      (b) any Company Shares then held by Parent, Acquisition Sub or any other wholly owned Subsidiary of Parent shall cease to exist, and no consideration shall be paid in exchange therefor;
      (c) except as provided in clauses “(a)” and “(b)” above, each Company Share then outstanding (including any outstanding Company Shares subject to any repurchase rights in favor of the Company, but excluding any Appraisal Shares (as defined in Section 2.8(c)), shall be converted into the right to receive the Per Share Amount in cash or such greater cash amount as may have been paid for any Company Shares pursuant to the Offer without interest; and
      (d) each share of common stock, par value $0.001 per share, of Acquisition Sub then outstanding shall be converted into one share of the common stock of the Surviving Corporation.
If, between the date of this Agreement and the Effective Time, the outstanding Company Shares are changed into a different number or class of shares by reason of any stock split, division or subdivision of shares, stock dividend, reverse stock split, consolidation of shares, reclassification, recapitalization or other similar transaction, then the Per Share Amount shall be adjusted to the extent appropriate.
      2.6 Closing of the Company’s Transfer Books. At the Effective Time: (a) all Company Shares outstanding immediately prior to the Effective Time shall cease to exist as provided in Section 2.5 and all holders of certificates representing Company Shares that were outstanding immediately prior to the Effective Time shall cease to have any rights as stockholders of the Company; and (b) the stock transfer books of the Company shall be closed with respect to all Company Shares outstanding immediately prior to the Effective Time. No further transfer of any such Company Shares shall be made on such stock transfer books after the Effective Time. If, after the Effective Time, a valid certificate previously representing any of such Company Shares (a “Company Stock Certificate”) is presented to the Paying Agent (as defined in Section 2.7) or to the Surviving Corporation or Parent, such Company Stock Certificate shall be canceled and shall be exchanged as provided in Section 2.7.

8


 
      2.7 Payment for Company Shares .
           (a) Prior to the Effective Time: (i) Parent (after consultation with and approval of the Company) shall select a reputable bank or trust company to act as paying agent with respect to the Merger (the “Paying Agent”); and (ii) Parent shall cause Acquisition Sub to make available to the Paying Agent cash amounts sufficient to enable the Paying Agent to make payments pursuant to Section 2.5 to holders of Company Shares outstanding immediately prior to the Effective Time.
           (b) Promptly after the Effective Time, Parent shall cause the Paying Agent to mail to each Person who was, immediately prior to the Effective Time, a holder of record of Company Shares described in Section 2.5(c) a form of letter of transmittal (mutually approved by Parent and the Company) and instructions for use in effecting the surrender of Company Stock Certificates representing such Company Shares in exchange for payment therefor. Parent shall ensure that, upon surrender to the Paying Agent of each such Company Stock Certificate, together with a properly executed letter of transmittal, the holder of such Company Stock Certificate (or, under the circumstances described in Section 2.7(e), the transferee of the Company Shares represented by such Company Stock Certificate) shall promptly receive in exchange therefor the amount of cash to which such holder (or transferee) is entitled pursuant to Section 2.5(c); provided , however , that Parent, the Surviving Corporation or the Paying Agent shall be entitled to deduct and withhold from the consideration otherwise payable to any holder of Company Shares surrendering Company Shares to the Paying Agent such amounts as Parent, the Surviving Corporation or the Paying Agent are required to deduct and withhold with respect to the making of such payment under the Code or any provision of state, local or foreign tax law. To the extent amounts are so withheld and paid over to the appropriate taxing authority by Parent, the Surviving Corporation or the Paying Agent, such withheld amounts shall be treated for all purposes as having been paid to the holder of Company Shares in respect of which such deduction and withholding was made by Parent, the Surviving Corporation or the Paying Agent.
           (c) On or after the first anniversary of the Effective Time, the Surviving Corporation shall be entitled to cause the Paying Agent to deliver to the Surviving Corporation any funds made available to the Paying Agent pursuant to Section 2.7(a)(ii) hereof which have not been disbursed to holders of Company Stock Certificates, and thereafter such holders shall be entitled to look to Parent and the Surviving Corporation with respect to the cash amounts payable upon surrender of their Company Stock Certificates. Neither the Paying Agent nor the Surviving Corporation shall be liable to any holder of a Company Stock Certificate for any amount properly paid to a public official pursuant to any applicable abandoned property or escheat law.
           (d) If any Company Stock Certificate shall have been lost, stolen or destroyed, then, upon the making of an affidavit reasonably acceptable to Parent of that fact by the Person claiming such Company Stock Certificate to be lost, stolen or destroyed, and, if required by the Surviving Corporation, the posting by such Person of such bond or surety as is customary and reasonable as indemnity against any claim that may be made against the Surviving Corporation with respect to such Company Stock Certificate, Parent shall cause the Paying Agent to pay in exchange for such lost, stolen or destroyed Company Stock Certificate the cash amount payable in respect thereof pursuant to this Agreement.

9


 
           (e) In the event of a transfer of ownership of Company Shares which is not registered in the transfer records of the Company, payment may be made with respect to such Company Shares to a transferee of such Company Shares if the Company Stock Certificate representing such Company Shares is presented to the Paying Agent, accompanied by all documents reasonably required by the Paying Agent to evidence and effect such transfer and to evidence that any applicable stock transfer taxes relating to such transfer have been paid.
           (f) The Surviving Corporation shall bear and pay all charges and expenses, including those of the Paying Agent, incurred in connection with the payment for Company Shares.
      2.8 Appraisal Rights.
           (a) Notwithstanding anything to the contrary contained in this Agreement, any Company Shares that constitute Appraisal Shares (as defined in Section 2.8(c)) shall not be converted into or represent the right to receive payment in accordance with Section 2.5, and each holder of Appraisal Shares shall be entitled only to such rights with respect to such Appraisal Shares as may be granted to such holder pursuant to Section 262 of the DGCL. From and after the Effective Time, a holder of Appraisal Shares shall not have and shall not be entitled to exercise any of the voting rights or other rights of a stockholder of the Surviving Corporation. If any holder of Appraisal Shares shall fail to perfect or shall otherwise lose such holder’s right of appraisal under Section 262 of the DGCL, then: (i) any right of such holder to require the Surviving Corporation to purchase such Appraisal Shares for cash shall be extinguished; and (ii) such Appraisal Shares shall automatically be converted into and shall represent only the right to receive (upon the surrender of the Company Stock Certificate(s) representing such Appraisal Shares) payment for such Appraisal Shares in accordance with Section 2.5.
           (b) The Company: (i) shall give Parent written notice of any demand by any stockholder of the Company for appraisal of such stockholder’s Company Shares pursuant to Section 262 of the DGCL; and (ii) shall give Parent the opportunity to participate in all negotiations and proceedings with respect to any such demand. Except with the prior written consent of Parent, the Company shall not voluntarily make any payment with respect to any demands for appraisal or settle or offer to settle any such demands for appraisal.
           (c) For purposes of this Agreement, “Appraisal Shares” shall refer to any Company Shares outstanding immediately prior to the Effective Time that are held by stockholders who have preserved their appraisal rights under Section 262 of the DGCL with respect to such Company Shares.
      2.9 Further Action . If, at any time after the Effective Time, any further action is necessary to carry out the purposes of this Agreement, the officers and directors of the Surviving Corporation and Parent shall (in the name of Acquisition Sub, in the name of the Company or otherwise) take such action.
SECTION 3 . REPRESENTATIONS AND WARRANTIES OF THE COMPANY

10


 
     The Company represents and warrants to Parent and Acquisition Sub that, except as set forth in the disclosure schedule delivered to Parent on the date of this Agreement (the “Company Disclosure Schedule”):
      3.1 Due Organization and Good Standing; Subsidiaries.
           (a) Each of the Company and its Subsidiaries is a corporation duly organized, validly existing and (where such concept is recognized under the laws of the jurisdiction in which it is incorporated) in good standing under the laws of the jurisdiction in which it is incorporated, and has all requisite corporate power and authority necessary to carry on its business as it is now being conducted. The Company and each of its Subsidiaries is duly qualified to do business and is in good standing in each state in which the nature of the business conducted by it makes such qualification necessary, except where the failure to be so qualified, individually or in the aggregate, does not constitute a Company Material Adverse Effect.
           (b) Part 3.1 of the Company Disclosure Schedule lists all Subsidiaries of the Company, together with the jurisdiction of organization of each such Subsidiary. All the outstanding shares of capital stock of each Subsidiary of the Company have been duly authorized and validly issued, are fully paid and nonassessable and are owned directly or indirectly by the Company free and clear of all liens, pledges or encumbrances, except for Permitted Encumbrances.
           (c) Other than equity interests in the Subsidiaries held by the Company or any of its Subsidiaries, there are no outstanding (i) securities of the Company or any of its Subsidiaries convertible into or exchangeable for shares of capital stock of or other voting securities or ownership interests in any Subsidiary of the Company, (ii) options, warrants or other rights or arrangements to acquire from the Company or any of its Subsidiaries, or other obligations or commitments of the Company or any of its Subsidiaries to issue, any capital stock of or other voting securities or ownership interests in, or any securities convertible into or exchangeable for any capital stock of or other voting securities or ownership interests in, any Subsidiary of the Company or (iii) restricted shares, restricted share units, stock appreciation rights, performance shares, contingent value rights, “phantom” stock or similar securities or rights to acquire any capital stock or other voting securities or ownership interests in any Subsidiary of the Company. Except for securities or interests classified as marketable securities or short-term investments under GAAP, as of the date hereof, neither the Company nor any of its Subsidiaries owns any capital stock or other equity interest in, or any interest convertible, exchangeable or excisable for, any such capital stock or other equity interest in, any Person (other than a Subsidiary of the Company).
      3.2 Certificate of Incorporation; Bylaws. The Company has delivered or made available to Parent copies of the certificate of incorporation and bylaws of the Company, including all amendments thereto. The Company is not in violation of its certificate of incorporation or bylaws.

11


 
      3.3 Capitalization, Etc.
           (a) The authorized capital stock of the Company consists of 60,000,000 Company Shares and 3,000,000 shares of preferred stock, par value $0.001 per share (“Preferred Shares”), 600,000 of which are designated as Series A Junior Participating Preferred Stock (“Junior Preferred Stock”). As of January 25, 2007: (i) 16,493,470 Company Shares were issued (and not held by the Company as treasury shares) and outstanding; (ii) 4,317,330 Company Shares were held by the Company as treasury shares; (ii) no Preferred Shares were outstanding; (iii) 600,000 shares of Junior Preferred Stock were reserved for future issuance upon exercise of the Company Rights; and (iv) 3,492,232 Company Shares were reserved for future issuance pursuant to the Company Option Plans, of which 2,487,243 Company Shares were subject to outstanding options to acquire Company Shares from the Company. From January 25, 2007 to the date of this Agreement, the Company has not issued any Company Shares other than resulting from the exercise of options reflected in the immediately preceding sentence as outstanding as of January 25, 2007. The Company has delivered or made available to Parent copies of: (A) the Company Option Plans, which cover the stock options granted by the Company that are outstanding as of the date of this Agreement; and (B) the forms of all stock option agreements with respect to the Company Option Plans.
           (b) Except for options, rights, securities and plans referred to in Section 3.3(a) and in the Company Rights Agreement, as of the date of this Agreement, there is no: (i) outstanding option or right to acquire from the Company any shares of the capital stock of the Company; (ii) outstanding security of the Company that is convertible into or exchangeable for any Company Shares or (iii) securities or contractual rights that give any Person the right to receive any economic interest of a nature accruing to the holders of Common Stock.
      3.4 SEC Filings; Financial Statements.
           (a) All registration statements (on a form other than Form S-8), annual, quarterly and periodic reports and definitive proxy statements required to be filed by the Company with the SEC between January 1, 2006 and the date of this Agreement (the “Company SEC Documents”) have been so filed. As of the time it was filed with the SEC (or, if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing): (i) each of the Company SEC Documents complied in all material respects with the applicable requirements of the Securities Act or the Exchange Act (as the case may be); and (ii) none of the Company SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has made available to Parent copies of all comment letters received by the Company from the SEC since January 1, 2006 and relating to the Company SEC Documents, together with all written responses of the Company thereto sent to the SEC. As of the date of this Agreement, there are no outstanding or unresolved comments in any comment letters received by the Company from the SEC. As of the date of this Agreement, to the knowledge of the Company, none of the Company SEC Documents is the subject of any ongoing review by the SEC.
           (b) The financial statements (including any related notes) contained in the Company SEC Documents fairly present, in all material respects, the consolidated financial

12


 
position of the Company and its Subsidiaries as of the respective dates thereof and the consolidated results of operations of the Company and its Subsidiaries for the periods covered thereby in accordance with GAAP applied on a consistent basis throughout the periods covered (except as may be indicated in the notes to such financial statements or, in the case of unaudited statements, as permitted by Form 10-Q of the SEC, and except that unaudited financial statements may not contain footnotes and are subject to year-end adjustments).
           (c) As of the date of this Agreement, neither the Company nor any of its Subsidiaries has any liabilities of the type required to be disclosed in the liabilities column of a balance sheet prepared in accordance with GAAP, except for: (i) liabilities disclosed in the financial statements (including any related notes) contained in the Company SEC Documents; (ii) liabilities incurred in the ordinary course of business since the date of the Latest Balance Sheet; and (iii) liabilities that are not material in the aggregate to the Company and its Subsidiaries taken as a whole.
           (d) The Company maintains disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act).
           (e) The Company maintains a system of internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) (“Internal Controls”). The Company had disclosed, as of the date of filing with the SEC its Quarterly Report on Form 10-Q for the quarter ended September 30, 2006, to the Company’s auditors and audit committee of its Board of Directors, to its knowledge, (x) all significant deficiencies and material weaknesses in the design or operation of Internal Controls which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information and (y) any fraud, whether or not material, that involves management or other employees who have a significant role in Internal Controls.
      3.5 Absence of Certain Changes. Between the date of the Latest Balance Sheet and the date of this Agreement, neither the Company nor any of its Subsidiaries has: (a) suffered any adverse change with respect to its business or financial condition that, individually or in the aggregate, constitutes a Company Material Adverse Effect; (b) suffered any material loss, damage or destruction to any of its material assets; (c) amended its certificate of incorporation or bylaws; (d) incurred any indebtedness for borrowed money or guaranteed any such indebtedness, except in the ordinary course of business; (e) changed, in any material respect, its accounting methods, principles or practices except as required by changes in GAAP; (f) sold or otherwise transferred any material assets, except in the ordinary course of business; (g) declared, set aside or paid any dividend with respect to the outstanding Company Shares; (h) made or changed any material tax election or settled any material tax claims, in each case other than in the ordinary course of business or (i) entered into any agreement to take any of the actions referred to in clauses “(c)” through “(h)” of this sentence.
      3.6 IP Rights.
           (a) (i) Part 3.6(a)(i) of the Company Disclosure Schedule sets forth a complete list of all patents, registered marks or trade dress, registered copyrights, registered designs, and registered domain names, along with all pending applications to issue or register the

13


 
same, owned by the Company or any Subsidiary (the “Registered IP”); (ii) the Company or one of its Subsidiaries is the sole and exclusive owner of all Registered IP and all Company IP, free of all liens and security interests (other than Permitted Encumbrances); (iii) neither the Company nor any of its Subsidiaries has granted any exclusive license to any such Registered IP or Company IP to any other Person (other than licenses which have expired, been terminated or are no longer in effect for any other reason). The Registered IP that is issued or registered is valid, subsisting and enforceable, and, to the knowledge of the Company as of the date of this Agreement, no action is threatened in writing or pending challenging the validity or enforceability of any Registered IP that is issued or registered; and (iv) to the knowledge of the Company, no third party is infringing any material IP Right of the Company or any Subsidiary.
           (b) (i) Except as would not cause a Company Material Adverse Effect, the Company and each of its Subsidiaries has the right and operational ability to exploit all IP Rights necessary to enable the Company to conduct its business substantially in the manner in which its business is currently being conducted. Except as would not cause a Company Material Adverse Effect, neither the Company nor any Subsidiary has infringed, improperly disclosed or misappropriated the IP Rights of any third party since January 1, 2005; and (ii) neither the Company nor any Subsidiary has been the subject of any suit, arbitration or administrative proceeding between January 1, 2005 and the date of this Agreement alleging, or received any other written notices from any third party between January 1, 2005 and the date of this Agreement alleging: (1) that the Company or any Subsidiary has infringed, improperly disclosed, misappropriated, converted or otherwise damaged the IP Rights of any third party; or (2) inviting or demanding that the Company or a Subsidiary take a license in order to avoid the future infringement of IP Rights of a third party.
           (c) Neither the Company nor any Subsidiary has entered into, except in the ordinary course of business, any written agreement to indemnify, defend or hold harmless any third party for or against any infringement, misappropriation, or other conflict with the IP rights of any third party. There are no suits or actions pending against the Company or any Subsidiary in which it is alleged that the Company or any Subsidiary has infringed, misappropriated or improperly disclosed the IP Rights of any third party.
           (d) The Company and its Subsidiaries have taken and are taking the following steps, to the extent that such steps are commercially reasonable and necessary to establish, perfect, and defend their ownership of Registered IP and Company IP or their right to use licensed third party IP Rights: (i) using appropriate patent, trademark and copyright designations on products and in marketing materials; (ii) requiring all employees and contractors who have invented inventions covered by patents owned by the Company or Subsidiary to assign all rights and interests in such inventions to the Company or relevant Subsidiary; and (iii) taking reasonable steps to protect trade secret information, including requiring a non-disclosure agreement before trade secret information is disclosed to a third party. The Company and its Subsidiaries, have complied, in all material respects, with all internal policies, applicable statutes, regulations, orders, and other legal requirements relating to the fair and proper use of personally identifiable information of employees and contractors of the Company and its Subsidiaries. To the knowledge of the officers of the Company who are aware of the transaction contemplated by this Agreement, no confidential or trade secret information of the Company, or personally identifiable information in the possession, custody or control of the Company or any

14


 
Subsidiary has been lost, stolen, or improperly disclosed. All persons identified as inventors in the patents owned by the Company or any Subsidiary have assigned all of their rights in the relevant inventions to the Company, relevant Subsidiary or predecessor in interest thereof.
           (e) (i) Except for third party Software commercially available in the market for licensing on standard terms, all Software sold or licensed by Company or its Subsidiaries to the customers of the Company and its Subsidiaries independently or bundled with other components, products or services of Company and its Subsidiaries, is owned entirely and exclusively by the Company or a Subsidiary and is free to be licensed or sold on the terms such Software is licensed or sold. The Company, directly or through its Subsidiaries, is in actual possession of or has necessary control over the source code and object code of all Software owned by the Company or any Subsidiary; (ii) neither the Company nor any Subsidiary has disclosed to any third party any source code of Software owned by the Company or any Subsidiary except pursuant to written source code escrow agreements containing license and confidentiality terms that reasonably protect the Company’s rights in such Software; and (iii) neither the Company nor any of its Subsidiaries is obligated to support or maintain any of the Software except pursuant to agreements that will terminate by their terms or are terminable by the Company (other than for cause) on a periodic basis and that provide for one or more payments to the Company or Subsidiary for the period of such services. To the knowledge of the Company, none of the Software owned the Company or its Subsidiaries contain any time bomb, virus, worm, trojan horse, back door, drop dead device, or any other code that would intentionally interfere with the normal operation of such Software, or that is intended to allow circumvention of security controls for the same, or that is intended to cause damage to hardware, software or data.
           (f) (i) No federal, state, local or other governmental entity, nor any university, college, or academic institution has financially sponsored research and development conducted by the Company or its Subsidiaries since January 1, 2005, or has rights in Software or IP Rights created since January 1, 2005 and purported to be owned by the Company or any Subsidiary; (ii) neither the Company nor any Subsidiary has participated in any standards-setting activities or joined any standards-setting or similar organizations that would affect the proprietary nature of any Software or IP Rights purported to be owned by the Company or any Subsidiary, or restrict the ability of the Company or any of its Subsidiaries to enforce, license or exclude others from using any Software or IP Rights purported to be owned by the Company or any Subsidiary; and (iii) none of the Software purported to be owned by the Company or any Subsidiary and incorporated by the Company or any Subsidiary into its products or services contain any open source code or other code or technology which would (1) require the public disclosure, third party distribution, or general licensing of Software or other IP Rights owned by the Company or any Subsidiary, (2) limit the ability of the Company or a Subsidiary to license or charge fees or royalties for such Software or IP Rights, or (3) require the Company or a Subsidiary to permit the reverse engineering, decompilation, disassembly, or creation of derivative works based upon of Software owned by the Company or a Subsidiary.
      3.7 Title to Assets; Real Property.
           (a) The Company or one of its Subsidiaries owns, and has good title to, each of the tangible assets reflected as owned by the Company or its Subsidiaries on the Latest

15


 
Balance Sheet (except for tangible assets sold or disposed of since that date and except for tangible assets being leased to the Company or one of its Subsidiaries) free of any liens or encumbrances (other than Permitted Encumbrances).
           (b) Neither the Company nor any of its Subsidiaries owns any real property.
           (c) Part 3.7 of the Company Disclosure Schedule sets forth a list of all real estate leases pursuant to which the Company or any of its Subsidiaries leases real property (the “Leased Real Property”) from any other Person (collectively, the “ Real Property Leases ”). Neither the Company nor any of its Subsidiaries is a party to any written or oral leases, subleases, licenses, concessions, occupancy agreements or other contractual obligations granting the right of use or occupancy of the Leased Real Property to any other Person.
           (d) The Company or one of its Subsidiaries has a valid and enforceable leasehold interest in each Leased Real Property with respect to which the gross monthly rent (including all base or minimum rent and all additional rent) under the applicable Real Property Lease equals or exceeds $25,000 (each a “Material Leased Location”), free and clear of all liens and encumbrances except for Permitted Encumbrances.
      3.8 Contracts.
           (a) Part 3.8(a) of the Company Disclosure Schedule contains a list of each of the following contracts that is in force and effect as of the date of this Agreement to which the Company or any of its Subsidiaries is a party: (i) each contract that would be required to be filed as an exhibit to a Registration Statement on Form S-1 under the Securities Act or an Annual Report on Form 10-K under the Exchange Act (if such registration statement or report was filed by the Company with the SEC on the date of this Agreement); (ii) each contract that restricts in any material respect the ability of the Company or any of its Subsidiaries to compete in any geographic area or line of business; (iii) each indemnification or employment contract with any director or officer of the Company or its Subsidiaries or with any employee or consultant of the Company or its Subsidiaries providing for an annual base salary or annual consulting fee to such employee or consultant of $150,000 or more in fiscal year 2006 (other than offer letters with employees providing for at-will employment); (iv) each loan or credit agreement, mortgage, note or other contract evidencing indebtedness for money borrowed by the Company or any of its Subsidiaries from a third party lender, and each contract pursuant to which any such indebtedness for borrowed money is guaranteed by the Company or any of its Subsidiaries; (v) each customer or supply contract (excluding purchase orders given or received in the ordinary course of business) under which the Company or any Subsidiary of the Company paid to or received from such customer or supplier in excess of $500,000 in fiscal year 2005 or fiscal year 2006; (vi) each material “single source” supply contract pursuant to which goods or materials are supplied to the Company or any Subsidiary of the Company from an exclusive source; (vii) each collective bargaining agreement; (viii) each Real Property Lease for a Material Leased Location; (ix) each lease or rental contract involving personal property (and not relating primarily to real property) pursuant to which the Company or any of its Subsidiaries is required to make rental payments in excess of $500,000 per year; (x) each contract relating to a joint venture, partnership or other strategic arrangement involving a sharing of costs, profits or losses with another Person; (xi) each contract with a distributor of the Company or any of its Subsidiaries (whether or not

16


 
exclusive); and (xii) each agreement that includes the grant to the Company or any of its Subsidiaries of a license to IP Rights owned by a third party and that is not a standard license agreement for a commercially available product (each contract listed in Part 3.8(a) of the Company Disclosure Schedule being referred to as a “Material Contract”). Each of the Material Contracts is valid and binding on the Company or the Subsidiary of the Company that is a party thereto and, to the knowledge of the Company, each other party thereto, and is in full force and effect, except where such failures to be valid and binding or to be in full force and effect do not constitute a Company Material Adverse Effect.
           (b) There is no existing breach or default on the part of the Company or any of its Subsidiaries under any Material Contract except for breaches and defaults that do not constitute a Company Material Adverse Effect and, to the knowledge of the Company, there is no existing breach or default on the part of any other Person under any Material Contract except for breaches and defaults that do not constitute a Company Material Adverse Effect. To the knowledge of the Company, no event has occurred that, with notice or lapse of time, would constitute a breach or default by the Company or any of its Subsidiaries, or permit termination, material modification or acceleration, under any Material Contract.
           (c) The Company has made available to Parent correct and complete copies of each Material Contract in effect as of the date of this Agreement, together with all amendments and supplements thereto in effect as of the date of this Agreement.
      3.9 Compliance with Legal Requirements. The Company and its Subsidiaries are in compliance with and have complied in a timely manner and in all respects with all Legal Requirements applicable to their businesses or relating to any of the property owned, leased or used by them (including the Foreign Corrupt Practices Act of 1977, any other Legal Requirements regarding use of funds for political activity or commercial bribery, the Sarbanes-Oxley Act of 2002, Legal Requirements relating to equal employment opportunity, discrimination, occupational safety and health, environmental matters, interstate commerce, anti-kickback, healthcare and antitrust, export control (including those Legal Requirements administered by the U.S. Department of Commerce and the U.S. Department of State) and asset control (including those Legal Requirements administered by the U.S. Department of the Treasury)), in each case except for non-compliance that individually or in the aggregate does not constitute a Company Material Adverse Effect.
      3.10 Legal Proceedings; Orders.
           (a) There is no Legal Proceeding pending (or, to the knowledge of the Company, being threatened) against the Company or any of its Subsidiaries, any present or former executive officer, director or employee of the Company or any of its Subsidiaries relating to his or her actions or inactions in such status or any other Person for whom the Company or any of its Subsidiaries would be liable, in each case that, individually or in the aggregate, constitutes a Company Material Adverse Effect.
           (b) There is no material court order or judgment specific to the Company or any of its Subsidiaries to which the Company or any of its Subsidiaries is subject.

17


 
      3.11 Governmental Authorizations. The Company and its Subsidiaries hold all Governmental Authorizations necessary to enable them to conduct their businesses in the manner in which such businesses are currently being conducted, except where failure to hold such Governmental Authorizations does not constitute a Company Material Adverse Effect. The material Governmental Authorizations held by the Company and its Subsidiaries are, in all material respects, valid and in full force and effect. The Company and its Subsidiaries are in compliance with the terms and requirements of such Governmental Authorizations, except where failure to be in compliance, individually or in the aggregate, does not constitute a Company Material Adverse Effect. Between January 1, 2006 and the date of this Agreement, neither the Company nor any of its Subsidiaries has received any written notice from any Governmental Entity: (a) asserting any material violation of any term or requirement of any material Governmental Authorization; or (b) notifying the Company or one of its Subsidiaries of the revocation of any material Governmental Authorization.
      3.12 Tax Matters.
           (a) All material tax returns required to be filed by the Company and its Subsidiaries with any Governmental Entities with respect to taxable periods ending before the Acceptance Time (including any schedule or attachment thereto or any amendment thereof) (the “Company Returns”): (i) have been or will be filed on or before the applicable due date (as such due date may have been or may be extended), and are, or will be when filed, true and accurate in all material respects. The Company and its Subsidiaries have timely paid or will timely pay any taxes due except to the extent such taxes are being contested in good faith and for which the Company or the appropriate Subsidiary has set aside adequate reserves. The Company has not been a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code.
           (b) The Latest Balance Sheet fully accrues the material liabilities of the Company and its Subsidiaries for taxes with respect to all periods through September 30, 2006 in accordance with GAAP and the unpaid taxes of the Company and its Subsidiaries as of the Acceptance Time will not exceed by a material amount the reserve for taxes set forth on the Latest Balance Sheet as adjusted for the passage of time through the Acceptance Time in accordance with the past custom and practice of the Company and its Subsidiaries in filing the Company Returns.
           (c) (i) There are no examinations or audits of any Company Return currently underway; (ii) no extension or waiver of the limitation period applicable to any Company Return is in effect; (iii) no Legal Proceeding is pending (or, to the knowledge of the Company, is being overtly threatened) by any tax authority against the Company or any of its Subsidiaries in respect of any material tax; (iv) there are no material unsatisfied liabilities for taxes with respect to any notice of deficiency or similar document received by the Company or any of its Subsidiaries with respect to any tax (other than liabilities for taxes asserted under any such notice of deficiency or similar document which are being contested in good faith); (v) there are no liens for material taxes (other than Permitted Encumbrances) upon any of the assets of the Company or any of its Subsidiaries; (vi) neither the Company nor any of its Subsidiaries has distributed stock of another corporation, or has had its stock distributed by another corporation, in a transaction that was governed, or purported or intended to be governed, in whole or in part, by section 355 of the

18


 
Code, (vii) neither the Company nor any of its Subsidiaries has entered into any transaction defined in Treasury Regulation section 1.6011-4(b) or has entered into a “potentially abusive tax shelter” (as defined in Treasury Regulation section 301.6112-1(b)); and (viii) neither the Company nor any of its Subsidiaries is bound by any agreement or consent entered into pursuant to Section 341(f) of the Code. Neither the Company nor any of its Subsidiaries is required to include any adjustment in taxable income for any tax period pursuant to Section 481 or 263A of the Code, and there are no applications pending with any Governmental Entity requesting permission for changes in any of the accounting methods of the Company or any of its Subsidiaries for tax purposes. Neither the Company nor any of its Subsidiaries has been a member of any combined, consolidated or unitary group for which it is or will be liable for taxes under principles of or similar to Section 1.1502-6 of the Treasury Regulations.
           (d) There is no agreement between the Company or any of its Subsidiaries and any employee or independent contractor of the Company or any of its Subsidiaries that will give rise to any payment that would not be deductible pursuant to Section 280G or Section 162 of the Code. Neither the Company nor any of its Subsidiaries is a party to any material tax indemnity agreement, tax sharing agreement, tax allocation agreement or similar contract with a third party.
           (e) For purposes of this Agreement, “tax” or “taxes” shall mean (i) any and all federal, state, local, or foreign income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental, customs duties, capital stock, franchise, profits, withholding, social security (or similar, including FICA), unemployment, disability, real property, personal property, sales, use, transfer, registration, value added,

 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more